| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | |
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit before income taxes | 69,013 | 93,320 | 132,378 | 146,840 | 138,901 |
| Depreciation and amortization | 49,390 | 47,950 | 50,211 | 57,362 | 60,811 |
| Impairment losses | 7,327 | 6,011 | 5,986 | 4,036 | 1,651 |
| Increase (decrease) in defined benefit liabilities | 2,677 | 1,878 | 691 | 1,270 | 1,371 |
| Decrease (increase) in trade and other receivables | 12,805 | -21,058 | -10,118 | 44,492 | -19,033 |
| Decrease (increase) in inventories | -5,132 | -7,607 | -14,000 | -2,230 | 11,769 |
| Increase (decrease) in trade and other payables | -4,899 | 9,234 | 440 | -15,779 | 3,804 |
| Increase (decrease) in advances received | - | 3,560 | 13,897 | -17,420 | -1,312 |
| Interest and dividend income | 822 | 587 | 569 | 1,283 | 2,065 |
| Interest expenses paid | -650 | -617 | -535 | -538 | -609 |
| Income taxes (paid) refunded | -13,332 | -24,560 | -30,445 | -38,748 | -41,030 |
| Others | 5,619 | 7,610 | -4,587 | 1,133 | -2,868 |
| Net cash provided by (used in) operating activities | 123,641 | 116,309 | 144,489 | 181,702 | 155,521 |
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment and intangible assets | -59,797 | -57,724 | -58,958 | -65,921 | -67,774 |
| Proceeds from sale of property, plant and equipment and intangible assets | 1,444 | 341 | 881 | 350 | 602 |
| Decrease (increase) in time deposits | -1,941 | 769 | -398 | 81 | -2,465 |
| Purchase of investment securities | -1,236 | -507 | -596 | -177 | -723 |
| Proceeds from sale of investment securities | 1,531 | 292 | 764 | 2,675 | 551 |
| Purchase of shares of subsidiaries and affiliates | - | -880 | -269 | -1,703 | - |
| Purchase of shares of subsidiaries resulting in change in scope of consolidation | - | - | - | -95,263 | - |
| Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation | - | - | - | - | 1,871 |
| Others | 7 | 170 | 982 | 51 | 10 |
| Net cash provided by (used in) investing activities | -59,991 | -57,538 | -57,594 | -159,906 | -67,927 |
| Cash flows from financing activities | |||||
| Net increase (decrease) in short-term borrowings | -336 | 428 | -315 | 29 | 72 |
| Repayment of lease liabilities | -4,735 | -5,199 | -5,228 | -5,567 | -7,631 |
| Decrease (increase) in treasury shares | -16,701 | -33,312 | 0 | -18,008 | -47,167 |
| Cash dividends paid | -29,820 | -30,188 | -31,076 | -34,046 | -36,041 |
| Others | -44 | -25 | -18 | -35 | -16 |
| Net cash provided by (used in) financing activities | -51,637 | -68,297 | -36,639 | -57,627 | -90,784 |
| Effect of exchange rate changes on cash and cash equivalents | -4,771 | 5,492 | 10,901 | 5,671 | 13,573 |
| Cash and cash equivalents included in assets held for sale | - | - | - | -1,920 | - |
| Reclassification of cash and cash equivalents included in assets held for sale in the opening balance | - | - | - | - | 1,920 |
| Net increase (decrease) in cash and cash equivalents | 7,240 | -4,034 | 61,157 | -32,079 | 12,302 |
| Cash and cash equivalents at the beginning of the period | 297,682 | 304,922 | 300,888 | 362,046 | 329,966 |
| Cash and cash equivalents at the end of the period | 304,922 | 300,888 | 362,046 | 329,966 | 342,269 |
